![](/img/cover-not-exists.png)
ATLANTIS: a Phase III study of lurbinectedin/doxorubicin versus topotecan or cyclophosphamide/doxorubicin/vincristine in patients with small-cell lung cancer who have failed one prior platinum-containing line
Farago, Anna F, Drapkin, Benjamin J, Lopez-Vilarino de Ramos, Jose Antonio, Galmarini, Carlos M, Núñez, Rafael, Kahatt, Carmen, Paz-Ares, LuisLanguage:
english
Journal:
Future Oncology
DOI:
10.2217/fon-2018-0597
Date:
October, 2018
File:
PDF, 2.67 MB
english, 2018